AmacaThera

AmacaThera is a Toronto-based biotechnology company focused on developing and commercializing a unique injectable hydrogel platform technology for a wide range of medical applications. Based on the research of world-renowned biomaterials scientist Dr. Molly Shoichet, AmacaThera is commercializing combination products at the interface of biomaterials and drugs. AmacaThera has developed a platform technology that addresses the critical issue of sustaining the delivery of pharmacological agents across multiple disease areas. Currently, a postoperative pain combination product has been developed.